News
Eminent physician-scientist Dr. Jonathan D. Licht to serve as next president and chief scientific officer of Van Andel Institute
Building a grand vision
Ted Heilman to succeed Kathleen Vogelsang as chief investment officer of Van Andel Institute
Harnessing the immune system to combat cancer: A Q&A with Postdoctoral Fellow Dr. Michael Dahabieh
Building a grand vision
Harnessing the immune system to combat cancer: A Q&A with Postdoctoral Fellow Dr. Michael Dahabieh
Not just a harmless accessory, tau’s ‘fuzzy coat’ contributes to Alzheimer’s progression
Midkine proteins prevent Alzheimer’s-related plaques
Eminent physician-scientist Dr. Jonathan D. Licht to serve as next president and chief scientific officer of Van Andel Institute
Ted Heilman to succeed Kathleen Vogelsang as chief investment officer of Van Andel Institute
Largest-ever Parkinson’s disease clinical trial opens
Cure Parkinson’s and Van Andel Institute announce Professor Matthew Farrer as winner of the 2025 Tom Isaacs Award
We’re here to help you tell your story.
Van Andel Institute is home to experts in a range of fields, including epigenetics, neurodegeneration, metabolism, structural and cellular biology, and K–12 STEM education.
The Institute’s Communications and Marketing Department assists journalists with information about the groundbreaking research happening at VAI. We can arrange interviews with VAI scientists and provide supporting materials, such as fact sheets, photographs and B-roll video to support the production of news packages. For press inquiries, please reach out to us at [email protected] or submit an inquiry below.
Media contacts
Beth Hinshaw, M.S.
Director, Communications & Marketing
616.234.5519
[email protected]
Zane McMillin
Multimedia Communications Manager, Communications & Marketing
[email protected]
Connect with us